Microfluidic methods for production of liposomes
- PMID: 19913165
- PMCID: PMC3790261
- DOI: 10.1016/S0076-6879(09)65007-2
Microfluidic methods for production of liposomes
Abstract
Liposomes are composed of lipid bilayer membranes that encapsulate an aqueous volume. A major challenge in the development of liposomes for drug delivery is the control of size and size distribution. In conventional methods, lipids are spontaneously assembled into heterogeneous bilayers in a bulk phase. Additional processing by extrusion or sonication is required to obtain liposomes with small size and a narrow size distribution. Microfluidics is an emerging technology for liposome synthesis, because it enables precise control of the lipid hydration process. Here, we describe a number of microfluidic methods that have been reported to produce micro/nanosized liposomes with narrower size distribution in a reproducible manner, focusing on the use of continuous-flow microfluidics. The advantages of liposome formation using the microfluidic approach over traditional bulk-mixing approaches are discussed.
Figures
Similar articles
-
Microfluidic directed formation of liposomes of controlled size.Langmuir. 2007 May 22;23(11):6289-93. doi: 10.1021/la070051a. Epub 2007 Apr 24. Langmuir. 2007. PMID: 17451256
-
Ultrasound-enhanced microfluidic synthesis of liposomes.Anticancer Res. 2010 Feb;30(2):463-6. Anticancer Res. 2010. PMID: 20332455 Free PMC article.
-
Microfluidic vortex focusing for high throughput synthesis of size-tunable liposomes.Nat Commun. 2022 Nov 16;13(1):6997. doi: 10.1038/s41467-022-34750-3. Nat Commun. 2022. PMID: 36384946 Free PMC article.
-
Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies.Curr Top Med Chem. 2024;24(14):1185-1211. doi: 10.2174/0115680266286460240220073334. Curr Top Med Chem. 2024. PMID: 38424436 Review.
-
Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities.Lab Chip. 2024 Feb 27;24(5):1154-1174. doi: 10.1039/d3lc00821e. Lab Chip. 2024. PMID: 38165786 Review.
Cited by
-
Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide.Mol Pharm. 2015 Apr 6;12(4):1279-88. doi: 10.1021/mp500815b. Epub 2015 Mar 18. Mol Pharm. 2015. PMID: 25751281 Free PMC article.
-
Toward the Scalable, Rapid, Reproducible, and Cost-Effective Synthesis of Personalized Nanomedicines at the Point of Care.Nano Lett. 2024 Jan 24;24(3):920-928. doi: 10.1021/acs.nanolett.3c04171. Epub 2024 Jan 11. Nano Lett. 2024. PMID: 38207109 Free PMC article.
-
Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.Curr Drug Metab. 2022;23(9):678-692. doi: 10.2174/1389200223666220609141459. Curr Drug Metab. 2022. PMID: 35692131 Review.
-
A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents.Bionanoscience. 2022;12(1):274-291. doi: 10.1007/s12668-022-00941-x. Epub 2022 Jan 26. Bionanoscience. 2022. PMID: 35096502 Free PMC article. Review.
-
On-chip microfluidic production of cell-sized liposomes.Nat Protoc. 2018 May;13(5):856-874. doi: 10.1038/nprot.2017.160. Epub 2018 Mar 29. Nat Protoc. 2018. PMID: 29599442
References
-
- Abraham SA, Waterhouse DN, Mayer LD, Cullis PR, Madden TD, Bally MB. The liposomal formulation of doxorubicin. Methods Enzymol. 2005;391:71–97. - PubMed
-
- Amselem S, Gabizon A, Barenholz Y. Optimization and upscaling of doxorubicin-containing liposomes for clinical use. J Pharm Sci. 1990;79:1045–1052. - PubMed
-
- Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238–252. - PubMed
-
- Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta. 1973;298:1015–1019. - PubMed
-
- Bhalerao SS, Raje Harshal A. Preparation, optimization, characterization, and stability studies of salicylic acid liposomes. Drug Dev Ind Pharm. 2003;29:451–467. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources